n-3 Polyunsaturated Fatty Acids (PUFAs) in the Prevention of Atrial Fibrillation

NCT01198275 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

199

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: n-3 PUFAs
DRUG: Placebo
DRUG: RASS inhibitors and/or RAS blockers
DRUG: Amiodarone

Sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia